David Brookes is listed as a director on 1 SEC Form D filing by 1 issuer in Jun 2024: Island Pharmaceuticals Ltd (Camberwell, Australia (as filed: C3) — biotechnology — 2024; $1.22M reported sold to 4 investors).
What this means One deal on file with the SEC, filed Jun 2024. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 2 bankruptcy cases matching the name listed in Key records below.
What this means 2 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 1 public filing for David Brookes and found 1 difference, 1 worth asking the sponsor about: Form D filed 92 days after the first sale.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.